← Leaderboards
Molly L Bristol
Virginia Commonwealth University
$294,976
Attributed
$294,976
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $147.5K · FY2020–21$200K$150K$100K$50K$0
'20
'21
Funding mix
By agency
NIH$294,976 · 1
By mechanism
R03$294,976 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Prakash S. Nagarkatti$24,802,981
- Barbara D. Boyan$11,261,791
- Joshua (chuck) Harrell$3,090,169
- William Gregory Hundley$19,718,962
- Karen S Ingersoll$10,539,581
Others in their field
Other Emerging Leaders on “Antiviral Agents”
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
- George Robert Painter · University Of Alabama At Birmingham$13,445,391
- David Yoo · Genbody Inc.$10,295,000
- Kristen A Johnson · California Institute/Biomedical Research$8,530,970
- Gary Kobinger · University Of Texas Med Br Galveston$7,131,815
Research focus
Antiviral AgentsAreaAttenuatedAttenuationBase PairingBindingBloodBypassCancer BurdenCancer CellCancer Cell GrowthCancer EtiologyCancer TherapyCarcinogenesisCarcinogensCell GrowthCell KillingCell LineCellsCell SurvivalClinicClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsAffect